Silicon Valley Bank January 9, 2025

Key takeaways

Our Healthcare Investments and Exits report shows a surge in biotech AI investment, strong early-stage momentum and mixed signals from valuation trends.

$5.6B

Invested in biotech AI in 2024

Driven largely by mega-deals, investment in biotech AI nearly tripled.

Nearly 40%

Of all healthcare deals with a declared Series went to seed-stage companies

Seed and Series A rounds claimed a majority of healthcare deals in 2024.

1

Number of healthcare subsectors experiencing a drop in down and flat rounds

Market corrections may be starting to wind down in biotech, devices and diagnostics/tools.

The Data

2024 was...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Investments, Mergers & Acquisitions / JV, Pharma / Biotech, Survey / Study, Technology, Trends
BridgeBio oncology spinout to go public in blank-check merger
Zoom invests in AI startup Suki
What's next for healthcare private equity?
KODE Raises $27M in Series B Funding to Transform Medical Coding and Data Management
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs

Share This Article